Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06205706 |
| Title | BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | BioInvent International AB |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | SWE | ESP | DNK | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Rigshospitalet | Copenhagen | Denmark | Details | |||
| Universitätsklinikum Essen | Essen | Germany | Details | |||
| Hospital HM Nou Delfos | Barcelona | 08023 | Spain | Details | ||
| HM Sanchinarro | Madrid | Spain | Details | |||
| Hospital Fundacion Jimenez Diaz | Madrid | Spain | Details | |||
| Hospital universitario Virgen del Rocio | Seville | Spain | Details | |||
| Lund University Hospital | Lund | Sweden | Details | |||
| Karolinska University Hospital, Solna | Stockholm | Sweden | Details |